pembrolizumab
pharmaceutical drug
Press Enter · cited answer in seconds
0 sources
pembrolizumab
Summary
pembrolizumab is a type of chemical entity[1]. pembrolizumab ranks in the top 0.4% of type_of_chemical_entity entities by monthly Wikipedia readership (2,809 views/month, #51 of 12,596).[2]
Key Facts
- pembrolizumab's instance of is recorded as type of chemical entity[3].
- pembrolizumab's physically interacts with is recorded as programmed cell death 1[4].
- pembrolizumab is a type of chemical compound[5].
- pembrolizumab is used for medication[6].
- pembrolizumab's route of administration is recorded as intravenous infusion and defusionههبهلخل[7].
- pembrolizumab's has characteristic is recorded as biopharmaceutical[8].
- pembrolizumab's mass is recorded as {'unit': 'Q483261', 'amount': '+149000'}[9].
- pembrolizumab's medical condition treated is recorded as colon cancer[10].
- pembrolizumab's medical condition treated is recorded as transitional cell carcinoma[11].
- pembrolizumab's medical condition treated is recorded as tongue squamous cell carcinoma[12].
- pembrolizumab's medical condition treated is recorded as melanoma[13].
- pembrolizumab's medical condition treated is recorded as bladder cancer[14].
- pembrolizumab's medical condition treated is recorded as Merkel cell carcinoma[15].
- pembrolizumab's medical condition treated is recorded as head and neck squamous cell carcinoma[16].
- pembrolizumab's medical condition treated is recorded as bladder urothelial carcinoma[17].
- pembrolizumab's medical condition treated is recorded as renal cell carcinoma[18].
- pembrolizumab's medical condition treated is recorded as non-small-cell lung carcinoma[19].
- pembrolizumab's medical condition treated is recorded as benign mesothelioma[20].
- pembrolizumab's medical condition treated is recorded as squamous cell carcinoma of the lung[21].
- pembrolizumab's medical condition treated is recorded as metastatic melanoma[22].
- pembrolizumab's World Health Organisation international non-proprietary name is recorded as {'lang': 'en', 'text': 'pembrolizumab'}[23].
- pembrolizumab's subject has role is recorded as immunological antineoplastic agent[24].
- pembrolizumab's subject has role is recorded as monoclonal antibody[25].
- pembrolizumab's active ingredient in is recorded as Keytruda[26].
- pembrolizumab's has active ingredient is recorded as Pembrolizumab[27].
Why It Matters
pembrolizumab ranks in the top 0.4% of type_of_chemical_entity entities by monthly Wikipedia readership (2,809 views/month, #51 of 12,596).[2] pembrolizumab has Wikipedia articles in 22 language editions, a strong signal of global cultural recognition.[28] pembrolizumab is known by 10 alternative names across languages and contexts.[29]